Lazard Asset Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$892K	Buy	39,470 +2,169	+6%	+$48.2K	﹤0.01%	1207
2025 Q4	$965K	Sell	37,301 -4,957	-12%	-$118K	﹤0.01%	1167
2025 Q3	$1.09M	Sell	42,258 -17,605	-29%	-$432K	﹤0.01%	1113
2025 Q2	$1.43M	Sell	59,863 -91,165	-60%	-$2.3M	﹤0.01%	1137
2025 Q1	$3.75M	Buy	151,028 +107,537	+247%	+$2.57M	0.01%	769
2024 Q4	$818K	Buy	+43,491	New	+$764K	﹤0.01%	1225
2023 Q4	–	Sell	-1,030	Closed	-$31K	–	2420
2023 Q3	$31K	Buy	+1,030	New	+$37.1K	﹤0.01%	2013
2023 Q2	–	Sell	-1,544	Closed	-$63K	–	2485
2023 Q1	$63K	Buy	+1,544	New	+$61.4K	﹤0.01%	1721
2022 Q2	–	Sell	-3,282	Closed	-$250K	–	2526
2022 Q1	$250K	Sell	3,282 -652	-17%	-$43.5K	﹤0.01%	1217
2021 Q4	$236K	Buy	+3,934	New	+$217K	﹤0.01%	1243
2020 Q3	–	Sell	-3,645	Closed	-$191K	–	1708
2020 Q2	$191K	Sell	3,645 -523	-13%	-$21.9K	﹤0.01%	925
2020 Q1	$139K	Buy	4,168 +3,351	+410%	+$139K	﹤0.01%	951
2019 Q4	$37K	Sell	817 -2,854	-78%	-$121K	﹤0.01%	1117
2019 Q3	$139K	Buy	+3,671	New	+$147K	﹤0.01%	957